Johannes Jacob Pieter Kastelein, the Chief Scientific Officer of $NAMS, sold 6,000 shares of the company on 01-05-2026 for an estimated $199,500. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.5% of their shares of this class of stock. Following this trade, they now own 73,481 shares of this class of $NAMS stock.
$NAMS Insider Trading Activity
$NAMS insiders have traded $NAMS stock on the open market 19 times in the past 6 months. Of those trades, 3 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $NAMS stock by insiders over the last 6 months:
- LOUISE FREDERIKA KOOIJ (Chief Accounting Officer) has made 0 purchases and 8 sales selling 323,989 shares for an estimated $9,817,789.
- JOHANNES JACOB PIETER KASTELEIN (Chief Scientific Officer) has made 0 purchases and 4 sales selling 106,000 shares for an estimated $2,671,139.
- DOUGLAS F KLING (Chief Operating Officer) has made 0 purchases and 3 sales selling 98,612 shares for an estimated $2,096,655.
- MAYUR IAN SOMAIYA (Chief Financial Officer) sold 5,118 shares for an estimated $170,173
- JAMES N TOPPER has made 3 purchases buying 2,391 shares for an estimated $58,420 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NAMS Hedge Fund Activity
We have seen 68 institutional investors add shares of $NAMS stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 3,630,743 shares (+190.6%) to their portfolio in Q3 2025, for an estimated $103,258,330
- CAPITAL WORLD INVESTORS added 1,434,986 shares (+17.1%) to their portfolio in Q3 2025, for an estimated $40,811,001
- FCPM III SERVICES B.V. removed 1,419,729 shares (-13.4%) from their portfolio in Q3 2025, for an estimated $40,377,092
- JENNISON ASSOCIATES LLC added 1,252,451 shares (+42.5%) to their portfolio in Q3 2025, for an estimated $35,619,706
- DUQUESNE FAMILY OFFICE LLC added 1,091,525 shares (+131.2%) to their portfolio in Q3 2025, for an estimated $31,042,971
- MORGAN STANLEY added 859,772 shares (+134.8%) to their portfolio in Q3 2025, for an estimated $24,451,915
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 849,260 shares (-16.6%) from their portfolio in Q3 2025, for an estimated $24,152,954
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NAMS Analyst Ratings
Wall Street analysts have issued reports on $NAMS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/06/2025
To track analyst ratings and price targets for $NAMS, check out Quiver Quantitative's $NAMS forecast page.
$NAMS Price Targets
Multiple analysts have issued price targets for $NAMS recently. We have seen 7 analysts offer price targets for $NAMS in the last 6 months, with a median target of $46.0.
Here are some recent targets:
- James Condulis from Stifel set a target price of $50.0 on 12/16/2025
- Asad Haider from Goldman Sachs set a target price of $37.0 on 12/02/2025
- Leonid Timashev from RBC Capital set a target price of $44.0 on 11/06/2025
- Serge Belanger from Needham set a target price of $46.0 on 11/05/2025
- Joseph Pantginis from HC Wainwright & Co. set a target price of $52.0 on 10/20/2025
- Geoff Meacham from Citigroup set a target price of $50.0 on 10/17/2025
- Yanan Zhu from Wells Fargo set a target price of $45.0 on 08/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
